Cover Image
市場調查報告書

自行注射型特殊藥物市場 ∼2022年

Self-injectable Specialty Drugs to 2022

出版商 Greystone Research Associates 商品編碼 339681
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
自行注射型特殊藥物市場 ∼2022年 Self-injectable Specialty Drugs to 2022
出版日期: 2015年09月16日 內容資訊: 英文
簡介

由於壽命延長,慢性疾病和診斷的患者數增加。這樣的動向帶給財政及醫療基礎設施的響,對於對患者友善且成本效益的高的給藥途徑的關注高漲。製藥公司決策者們,認識著僅僅只醫藥品不是依賴,而是適合消費者的包裝和滿足用途的事成功的關鍵。

一般認為

本報告提供自行注射型特殊藥物市場相關調查、市場現狀與至2022年的市場預測、各治療市場區隔趨勢,及參與企業簡介彙整。

摘要整理

自行注射型特殊藥物市場趨勢

  • 注射劑的需求促進要素
    • 藥物開發因素
    • 市場因素
    • 技術因素
  • 自行注射型產品設計因素
    • 可用性
    • 安全性和簡便
    • 患者的介面
  • 競爭環境
  • 風險與機會

自行注射型給藥設備選擇標準

  • 單回對多劑量設備
  • 固定劑量及各種劑量
  • 冷凍乾燥藥物/重組
  • 拋棄式對可重複使用設備
  • 人機學/人體工學
  • 品牌/自有品牌

自行注射型特殊藥物:設備類別

  • 自動注射器
  • 無針頭注射器
  • 筆注射器
  • 預填充注射器
  • 穿戴式注射設備
  • 特殊設備

產品分析,治療市場區隔評估及預測

  • 過敏性反應
  • 抗凝固劑
  • 抗病毒藥物
  • 自體免疫疾病
  • 血液因子
  • 急救
  • 造血
  • 遺傳性疾病
  • 荷爾蒙置換療法
  • 感染疾病
  • 代謝性疾病

企業簡介

目錄
Product Code: SSD333R

The Convergence of Therapy & Delivery

Increases in life expectancy are expected to result in a growing number of patients diagnosed with chronic conditions. To counteract the financial and logistical implications of this trend, pressure from public health and managed care organizations will place a premium on therapeutic self-administration Specialty Injectable formulation and packaging decisions are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships.

The value we provide to our clients and subscribers is best illustrated by our ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Tailored Research

As technology and products evolve, the level of precision in management decisions required to enable effective company performance is increasing. Such precision cannot be achieved without timely and accurate data about the company's macroscopic operating environment. The information that you and your management team require to execute your business and market strategies is unique to your organization and business model. This is why - in addition to the multi-client reports you will find on our site - we offer client-specific research services that start with customer-defined needs and culminate in assessments and analysis that answer the questions that represent risk to your business strategy. To discuss Greystone's Customer Defined Research services, we invite you to contact us.

‘For injectables, developers must often anticipate the evolution of the product through a complex product life cycle that can include migration from one delivery/packaging stage to another over the course of the first twenty-four months, - a scenario that has not been uncommon for biologicals such as immune modulators, which are often commercialized in vials before migrating to prefilled devices. Experience with the new drug design paradigm is making this migration less necessary.’

What You Will Learn

  • What are the currently marketed specialty injectable drugs intended for patient self administration?
  • What are the therapeutic demand drivers for self-injectable specialty drugs and what are their growth prospects?
  • What are the key formulation and packaging factors and market development issues for self-administered specialty injectables?
  • What does the current self-injectable specialty drug market look like, who are the market leaders, and what will this market look like in 2022?
  • What are the important therapeutic market segments for self-injectable specialty drugs, how large are they, and how fast are they growing?
  • How important are pharma-device alliances and design partnerships in this market segment?
  • What is the impact of economic, technology, and regulatory factors in this market?

Table of Contents

Executive Summary

Self-Injectable Specialty Drug Market Dynamics

  • Injectable Drug Demand Drivers
    • Drug Development Factors
    • Market Factors
    • Technology Factors
  • Self-Injection Product Design Factors
    • Ease-of-Use
    • Safety and Simplicity
    • Patient Interface
  • Competitive Landscape
  • Risks and Opportunities

Self-injectable Delivery Device Selection Criteria

  • Single vs Multi-Dose Devices
  • Fixed vs Variable Dosing
  • Lyophilized Drugs/Reconstitution
  • Disposable vs Reusable Devices
  • Human Engineering/Ergonomics
  • Branding/Private Labeling

Self-injectable Specialty Drugs - Device Categories

  • Autoinjectors
  • Needle-free Injectors
  • Pen Injectors
  • Prefilled Syringes
  • Wearable Injection Devices
  • Specialty Devices

Self-injectable Specialty Drugs - Product Analysis, Therapeutic Segment Assessments & Forecasts

  • Anaphylaxis
  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Blood Factors
  • Emergency Medicine
  • Hematopoietics
  • Hereditary Diseases
  • Hormone Replacement
  • Infectious Disease
  • Metabolic Diseases
    • Glycemic Control
    • Osteoporosis
  • Neurology
  • Oncology
    • Hormones
    • Immune Modulators
  • Reproductive Health
  • Vaccines

Company Profiles

Back to Top